The institutional landscape for Rapport Therapeutics, Inc. (NASDAQ:RAPP) includes 139 filers as of the latest reporting cycle ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| TRV GP V, LLC | 31 Dec, 2025 | 7,135,233 | 0 | 0.00% | $216,482,969.00 |
| FMR LLC | 31 Dec, 2025 | 7,111,865 | 194,870 | 2.82% | $215,773,984.00 |
| ARCH Venture Management, LLC | 31 Dec, 2025 | 3,728,738 | 0 | 0.00% | $113,129,911.00 |
| Capital International Investors | 31 Dec, 2025 | 3,402,529 | 0 | 0.00% | $103,232,730.00 |
| Cormorant Asset Management, LP | 31 Dec, 2025 | 3,027,521 | -165,000 | -5.17% | $91,854,987.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 3,001,879 | 579,903 | 23.94% | $91,077,009.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 2,431,862 | 863,781 | 55.09% | $73,782,693.00 |
| Sofinnova Investments, Inc. | 31 Dec, 2025 | 1,904,408 | -43,171 | -2.22% | $57,779,739.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,817,757 | 191,219 | 11.76% | $55,150,747.00 |
| JOHNSON & JOHNSON | 31 Dec, 2025 | 1,784,517 | 0 | 0.00% | $54,142,246.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 1,547,090 | 0 | 0.00% | $46,938,711.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 1,110,000 | 160,000 | 16.84% | $33,677,400.00 |
| Polar Capital Holdings Plc | 31 Dec, 2025 | 1,004,728 | 65,776 | 7.01% | $30,483,448.00 |
| TRV GP VI, LLC | 31 Dec, 2025 | 969,218 | 0 | 0.00% | $29,406,074.00 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 31 Dec, 2025 | 952,371 | 60,113 | 6.74% | $28,894,936.00 |
| ALLIANCEBERNSTEIN L.P. | 31 Dec, 2025 | 788,411 | -67,209 | -7.86% | $23,920,390.00 |
| STATE STREET CORP | 31 Dec, 2025 | 714,821 | 343,195 | 92.35% | $21,687,669.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 708,469 | -345,000 | -32.75% | $21,494,949.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 694,734 | 161,331 | 30.25% | $21,081,433.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 673,923 | 270,000 | 66.84% | $20,446,824.00 |